Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 554.25M P/E - EPS this Y - Ern Qtrly Grth -
Income -75.55M Forward P/E - EPS next Y - 50D Avg Chg -14.00%
Sales 1.65M PEG - EPS past 5Y - 200D Avg Chg -24.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -60.00%
Recommedations - Quick Ratio 0.05 Shares Outstanding 1.25B 52W Low Chg 13.00%
Insider Own 8.88% ROA -137.16% Shares Float 1.14B Beta -0.59
Inst Own 0.05% ROE - Shares Shorted/Prior 14.14M/13.83M Price 0.51
Gross Margin - Profit Margin - Avg. Volume 1,414,462 Target Price -
Oper. Margin -3,424.31% Earnings Date Nov 7 Volume 2,452,201 Change -2.38%
About NORTHWEST BIOTHERAPEUTICS INC

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.

NWBO Chatroom

User Image followalmak Posted - 59 minutes ago

$NWBO Most of the stocks on fire CRMD, DJT....Many more madi it from ashes...except this one...this is going south...

User Image ICEMAN805 Posted - 1 hour ago

$NWBO https://www.the-sun.com/health/12669183/breakthrough-cancer-treatment-cure-death-sentence-tumours-disappear/

User Image Bajamike Posted - 1 hour ago

$NWBO ATLnsider @ATLnsider · 28m A lot of “pretend” $NWBO longs are posting today. Trying to create the impression that NWBio management is to blame and is responsible for the stock price being illegally manipulated & saying the MHRA #DCVax-L approval is delayed This is all orchestrated and coordinated by the collusive Market Makers, Hedge Funds, Short Sellers, and their army of social media surrogates who were frantically posting this morning, across all social media platforms. This is just a scare tactic to entice some weak hands, unconvicted or ill-informed longs to sell their shares, just before #DCVax-L is approved by the MHRA and the MTD ruling is made.

User Image ngocnu Posted - 1 hour ago

$NWBO added 5k at $0.265 shorties lol

User Image NorthvanVic Posted - 2 hours ago

$NWBO

User Image TJmaximus Posted - 2 hours ago

$NWBO the green moron morning marching brigade

User Image Stocksfirst Posted - 2 hours ago

$NWBO - Down Again on a very positive day. I see all the “bullish” notations with no reasons why. It would be funny if it wasn’t so sad!

User Image Bajamike Posted - 3 hours ago

$NWBO Project 1 Targeting Immunotherapy-induced Resistance with DC Vaccination and Immune Modulation The overall goals of this project are to investigate mechanisms of immune evasion following treatment with dendritic cell (DC) vaccines, and to develop rational combinations of immunotherapeutic strategies to overcome the immunosuppressive milieu of the brain tumor microenvironment. We previously found that, in addition to inducing T-cell infiltration into brain tumors, DC vaccination + anti-PD1 blockade may also create a pro-inflammatory environment within the tumor that induces the immigration of immunosuppressive myeloid cells (TIM). TIM are phenotypically similar to the myeloid cells that attenuate the T-cell response to chronic viral infections, and may counteract the anti-tumor T-cell responses induced by DC vaccination. Therapies that target myeloid cells within the tumor microenvironment represent a promising new strategy. As such, inhibition of these myeloid cells using a CSF-1R inhibitor, in conjunction with autologous tumor lysate-pulsed DC vaccination (ATL-DC) and PD-1 mAb blockade, resulted in significantly prolonged survival in tumor-bearing animals with large, well-established intracranial gliomas. Our hypothesis is that myeloid cells mediate adaptive immune resistance in response to T-cell activation induced by immunotherapy. We have planned a series of novel pre-clinical studies to re-polarize myeloid cells, to optimize how the timing and sequence of immunotherapy can influence ant-tumor immunity, and a new clinical trial to test the first-in-human combination of a new brain penetrant CSF-1R inhibitor (CSF-1Ri; PLX3397, Daiichi-Sankyo) with DC vaccination and PD-1 mAb blockade (Pembrolizumab, Merck) in patients with newly diagnosed GBM. A better understanding of the biology of these cellular interactions will provide insight into more effective ways to induce therapeutic anti-tumor immune responses for this deadly type of brain tumor. Aim 1: To identify the optimal timing and sequence by which immunotherapy alters the local tumor-infiltrating immune response in syngeneic murine glioma models and in recurrent glioblastoma patients. Aim 2: To conduct a new first-in-human Phase I clinical trial of ATL-DC vaccination in conjunction with CSF-1R inhibitor (PLX3397) and PD-1 mAb (Pembrolizumab) blockade, and develop predictive immunological and imaging biomarkers. Aim 3: To elucidate the immunotherapy-induced resistance mechanisms by which immuno-suppressive myeloid cells inhibit anti-tumor immune responses in pre-clinical animal models and in newly diagnosed glioblastoma patients.

User Image Nicksv11 Posted - 3 hours ago

$NWBO

User Image Bajamike Posted - 3 hours ago

$NWBO Bear raid to take out stop loss orders , which facilitates short covering.What news do the shorts think is coming? @flaskworks : "Yes, shorts want us to sell our derisked $NWBO shares right before approval so they can close their short positions then go long. Hedge funds make money when stocks go down as well as when they go up. This is what being market neutral means. They always win but so will retail!" "

User Image Trate121 Posted - 3 hours ago

$NWBO

User Image Jeff226 Posted - 3 hours ago

$NWBO Long and Strong!

User Image Makeitcometrue Posted - 3 hours ago

$NWBO 😂😂😂😂😂 Weak! Pump Harder!!!!😂😂😂

User Image Trate121 Posted - 4 hours ago

$NWBO

User Image LongStocking Posted - 4 hours ago

$NWBO Picked up another 10k today. 😀

User Image Cocacola1971 Posted - 4 hours ago

$NWBO any positive acronyms are welcome. 😁👍👍

User Image Cocacola1971 Posted - 4 hours ago

$NWBO Next Week Best Opportunity Never Wavering Being optimistic

User Image Ttubular Posted - 4 hours ago

$NWBO we must be getting close to approval because they dropped us fast to .25 lol

User Image Cocacola1971 Posted - 5 hours ago

$NWBO man oh man! so cheap right now. i wish my stupid $75 would hurry up and clear.

User Image MBD Posted - 5 hours ago

$NWBO Stuck in the daily fish-hook chart trend, or as some describe it, a non-stop buying op. Which is also why I prefer weekends - the stock can't drop.

User Image DeepThought Posted - 6 hours ago

$NWBO First match ball at the end of next week

User Image T_B Posted - 6 hours ago

$NWBO It hit almost .25 today??? I need to sell some stuff for about $ 100,000. Does anyone want to buy one kidney and half a liver? Both are in pretty good shape, low mileage (odometer MAY be broken), new tires, no dents, one 6mm calcium oxalate stone. Price is firm. Not interested in any trades or barter.

User Image Trate121 Posted - 6 hours ago

$NWBO

User Image archetypal Posted - 6 hours ago

$NWBO Like any serious longs are going to sell at this point?

User Image mrstock85DK Posted - 6 hours ago

$NWBO when I saw - 12% before the first hour without any news I already called it.. We gonna end green IMO

User Image CCURN4ever Posted - 7 hours ago

@bernardkeogh big volume and more basher posts likely equals something good. Go $NWBO

User Image LongStocking Posted - 7 hours ago

$NWBO

User Image DeepThought Posted - 7 hours ago

$NWBO

User Image bernardkeogh Posted - 7 hours ago

$NWBO the shorts are out in force on all platforms today,lol GLTA

User Image 3Aces4now Posted - 7 hours ago

$NWBO Even more

Analyst Ratings
Oppenheimer Perform Mar 12, 14
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
MALIK NAVID Director Director Nov 16 Sell 0.83 570,000 473,100 12/01/23